Alfa-1A adrenergički receptor

Iz Wikipedije, slobodne enciklopedije
Idi na navigaciju Idi na pretragu
edit
Adrenergički alfa-1A receptor
Identifikatori
SimboliADRA1A; ADRA1C; ADRA1L1; ALPHA1AAR
Vanjski IDOMIM104221 MGI104773 HomoloGene68078 IUPHAR: α1A-adrenoceptor GeneCards: ADRA1A Gene
Pregled RNK izražavanja
PBB GE ADRA1A 211492 s at tn.png
PBB GE ADRA1A 211490 at tn.png
PBB GE ADRA1A 211491 at tn.png
podaci
Ortolozi
VrstaČovekMiš
Entrez14811549
EnsemblENSG00000120907ENSMUSG00000045875
UniProtP35348Q8BUE5
RefSeq (mRNA)NM_000680NM_013461
RefSeq (protein)NP_000671NP_038489
Lokacija (UCSC)Chr 8:
26.66 - 26.78 Mb
Chr 14:
65.59 - 65.69 Mb
PubMed pretraga[1][2]

Alfa-1A adrenergički receptor (α1A adrenoreceptor, ADRA1A, alfa-1C adrenergički receptor) je alfa-1 adrenergički receptor. On je kodiran ADRA1A humanim genom.[1][2]

Receptor[uredi - уреди | uredi izvor]

Postoje 3 tipa alfa-1 adrenergičkog receptora: alfa-1A, -1B i -1D, svi od kojih prenose signal kroz Gq/11 familiju G-proteina. Različiti podtipovi pokazuju različite oblike aktivacije.

Gen[uredi - уреди | uredi izvor]

Alternativno splajsovanje ovog gena proizvodi različite transkriptne varijante, koje kodiraju četiri izoforme sa distinktinim C-terminusima. One imaju slična svojstva u pogledu vezivanja liganda.[1]

Ligandi[uredi - уреди | uredi izvor]

Agonisti[uredi - уреди | uredi izvor]

  • 6-(5-fluoro-2-pirimidin-5-il-fenil)-6,7-dihidro-5H-pirolo[1,2-a]imidazol EC50 = 1nM, Emax = 65%; dobra selektivnost u odnosu na α1B, α1D i α2A tipove[3]
  • više parcijalnih agonista sa imidazolnom osnovom[4][5]

Antagonisti[uredi - уреди | uredi izvor]

Vidi još[uredi - уреди | uredi izvor]

Reference[uredi - уреди | uredi izvor]

  1. 1,0 1,1 "Entrez Gene: ADRA1A adrenergic, alpha-1A-, receptor". http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=148. 
  2. Langer SZ (1998). "Nomenclature and state of the art on alpha1-adrenoceptors". Eur. Urol. 33 Suppl 2: 2–6. PMID 9556189. doi:10.1159/000052227. 
  3. Roberts LR, Fish PV, Ian Storer R, Whitlock GA (April 2009). "6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha(1A) adrenoceptor partial agonists". Bioorg. Med. Chem. Lett. 19 (11): 3113. PMID 19414260. doi:10.1016/j.bmcl.2009.03.166. 
  4. Whitlock GA, Brennan PE, Roberts LR, Stobie A (April 2009). "Potent and selective alpha(1A) adrenoceptor partial agonists-Novel imidazole frameworks". Bioorg. Med. Chem. Lett. 19 (11): 3118. PMID 19394220. doi:10.1016/j.bmcl.2009.03.162. 
  5. Roberts LR, Bryans J, Conlon K, McMurray G, Stobie A, Whitlock GA (December 2008). "Novel 2-imidazoles as potent, selective and CNS penetrant alpha1A adrenoceptor partial agonists". Bioorg. Med. Chem. Lett. 18 (24): 6437–40. PMID 18980842. doi:10.1016/j.bmcl.2008.10.066. 

Literatura[uredi - уреди | uredi izvor]

  • Mátyus P, Horváth K (1998). "Alpha-adrenergic approach in the medical management of benign prostatic hyperplasia.". Med Res Rev 17 (6): 523–35. PMID 9359081. doi:10.1002/(SICI)1098-1128(199711)17:6<523::AID-MED2>3.0.CO;2-3. 
  • Hoehe MR, Berrettini WH, Schwinn DA, Hsieh WT (1993). "A two-allele PstI RFLP for the alpha-1C adrenergic receptor gene (ADRA1C).". Hum. Mol. Genet. 1 (5): 349. PMID 1363873. doi:10.1093/hmg/1.5.349-a. 
  • Schwinn DA, Lomasney JW, Lorenz W et al. (1990). "Molecular cloning and expression of the cDNA for a novel alpha 1-adrenergic receptor subtype.". J. Biol. Chem. 265 (14): 8183–9. PMID 1970822. 
  • Hirasawa A, Shibata K, Horie K et al. (1995). "Cloning, functional expression and tissue distribution of human alpha 1c-adrenoceptor splice variants.". FEBS Lett. 363 (3): 256–60. PMID 7737411. doi:10.1016/0014-5793(95)00330-C. 
  • Diehl NL, Shreeve SM (1995). "Identification of the alpha 1c-adrenoceptor in rabbit arteries and the human saphenous vein using the polymerase chain reaction.". Eur. J. Pharmacol. 268 (3): 393–8. PMID 7805763. 
  • Schwinn DA, Johnston GI, Page SO et al. (1995). "Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues.". J. Pharmacol. Exp. Ther. 272 (1): 134–42. PMID 7815325. 
  • Weinberg DH, Trivedi P, Tan CP et al. (1994). "Cloning, expression and characterization of human alpha adrenergic receptors alpha 1a, alpha 1b and alpha 1c.". Biochem. Biophys. Res. Commun. 201 (3): 1296–304. PMID 8024574. doi:10.1006/bbrc.1994.1845. 
  • Forray C, Bard JA, Wetzel JM et al. (1994). "The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype.". Mol. Pharmacol. 45 (4): 703–8. PMID 8183249. 
  • Hirasawa A, Horie K, Tanaka T et al. (1993). "Cloning, functional expression and tissue distribution of human cDNA for the alpha 1C-adrenergic receptor.". Biochem. Biophys. Res. Commun. 195 (2): 902–9. PMID 8396931. doi:10.1006/bbrc.1993.2130. 
  • Tseng-Crank J, Kost T, Goetz A et al. (1996). "The alpha 1C-adrenoceptor in human prostate: cloning, functional expression, and localization to specific prostatic cell types.". Br. J. Pharmacol. 115 (8): 1475–85. PMC 1908895. PMID 8564208. 
  • Shibata K, Hirasawa A, Moriyama N et al. (1997). "Alpha 1a-adrenoceptor polymorphism: pharmacological characterization and association with benign prostatic hypertrophy.". Br. J. Pharmacol. 118 (6): 1403–8. PMC 1909672. PMID 8832064. 
  • Chang DJ, Chang TK, Yamanishi SS et al. (1998). "Molecular cloning, genomic characterization and expression of novel human alpha1A-adrenoceptor isoforms.". FEBS Lett. 422 (2): 279–83. PMID 9490024. doi:10.1016/S0014-5793(98)00024-6. 
  • Daniels DV, Gever JR, Jasper JR et al. (1999). "Human cloned alpha1A-adrenoceptor isoforms display alpha1L-adrenoceptor pharmacology in functional studies.". Eur. J. Pharmacol. 370 (3): 337–43. PMID 10334511. doi:10.1016/S0014-2999(99)00154-5. 
  • Cogé F, Guenin SP, Renouard-Try A et al. (1999). "Truncated isoforms inhibit [3H]prazosin binding and cellular trafficking of native human alpha1A-adrenoceptors.". Biochem. J. 343 Pt 1: 231–9. PMC 1220546. PMID 10493934. doi:10.1042/0264-6021:3430231. 
  • Rudner XL, Berkowitz DE, Booth JV et al. (1999). "Subtype specific regulation of human vascular alpha(1)-adrenergic receptors by vessel bed and age.". Circulation 100 (23): 2336–43. PMID 10587338. 
  • Ballou LM, Cross ME, Huang S et al. (2000). "Differential regulation of the phosphatidylinositol 3-kinase/Akt and p70 S6 kinase pathways by the alpha(1A)-adrenergic receptor in rat-1 fibroblasts.". J. Biol. Chem. 275 (7): 4803–9. PMID 10671514. doi:10.1074/jbc.275.7.4803. 
  • Keffel S, Alexandrov A, Goepel M, Michel MC (2000). "alpha(1)-adrenoceptor subtypes differentially couple to growth promotion and inhibition in Chinese hamster ovary cells.". Biochem. Biophys. Res. Commun. 272 (3): 906–11. PMID 10860850. doi:10.1006/bbrc.2000.2850. 
  • Richman JG, Brady AE, Wang Q et al. (2001). "Agonist-regulated Interaction between alpha2-adrenergic receptors and spinophilin.". J. Biol. Chem. 276 (18): 15003–8. PMID 11154706. doi:10.1074/jbc.M011679200. 
  • Shibata K, Katsuma S, Koshimizu T et al. (2003). "alpha 1-Adrenergic receptor subtypes differentially control the cell cycle of transfected CHO cells through a cAMP-dependent mechanism involving p27Kip1.". J. Biol. Chem. 278 (1): 672–8. PMID 12409310. doi:10.1074/jbc.M201375200. 

Spoljašnje veze[uredi - уреди | uredi izvor]